You are here

Consultation Summary: Strategies to Increase Hepatitis C Treatment Within ADAPs

November 2016

HRSA HIV/AIDS Bureau (HAB)

Consultation meeting regarding strategies to increase hepatitis C (HCV) treatment within ADAPs. Report features:

  • Participants in the consultation
  • Best practices in ADAP HCV treatment utilization
  • Round-robin discussions
  • Recommendations
  • Summary tables of ADAP formulary inclusion of directly-acting antiviral (DAA) HCV medications and coverage policies
Total views: 798